In vivo expression of HGF/NK1 and GLP-1 From dsAAV vectors enhances pancreatic ß-cell proliferation and improves pathology in the db/db mouse model of diabetes.
about
Immunomodulation of antigen presenting cells promotes natural regulatory T cells that prevent autoimmune diabetes in NOD mice.In vivo pancreatic β-cell-specific expression of antiaging gene Klotho: a novel approach for preserving β-cells in type 2 diabetesGlucagon-like peptide-1 gene therapyAntiaging Gene Klotho Attenuates Pancreatic β-Cell Apoptosis in Type 1 Diabetes.Prenatal expression of MET receptor tyrosine kinase in the fetal mouse dorsal raphe nuclei and the visceral motor/sensory brainstemGlobal gene expression profiling of pancreatic islets in mice during streptozotocin-induced β-cell damage and pancreatic Glp-1 gene therapy.One-time injection of AAV8 encoding urocortin 2 provides long-term resolution of insulin resistanceReprogramming gut and pancreas endocrine cells to treat diabetes.Mechanisms and clinical efficacy of lixisenatide for the management of type 2 diabetes.GLP-1-mediated gene therapy approaches for diabetes treatment.Islet cell plasticity and regeneration.AAV-mediated gene therapy for atherosclerosis.Overexpression of peroxisome proliferator-activated receptor α in pancreatic β-cells improves glucose tolerance in diet-induced obese mice.The global transcriptional response of isolated human islets of langerhans to glucagon-like Peptide-1 receptor agonist liraglutide.dsAAV8-mediated gene transfer and β-cell expression of IL-4 and β-cell growth factors are capable of reversing early-onset diabetes in NOD mice.Hepatocyte Growth Factor Isoforms in Tissue Repair, Cancer, and Fibrotic Remodeling.
P2860
Q34166274-53C527C7-211D-4BCA-A8BB-869DEFDB6A34Q34446705-662094C9-F437-4A66-8BBD-A7C9ABAB8324Q35071227-D51BCC21-0A54-43CA-930D-B8C1DCE18AFEQ36311562-3D6B4879-8980-45E3-8295-F46119615BCFQ37101439-6F8F0FDA-7C6D-4A64-AF8F-E8930F6F5E19Q37137787-83D005EB-B739-4EEC-BA97-CE10DDBAC1D3Q37277047-592A1D64-5A24-41CD-A332-5B1D7373DECBQ37913508-A7F5F179-44AA-4707-A9EF-0B026CC9C52FQ38083047-2FD77D18-2FBC-48E2-9BFE-710351B25071Q38199215-3E71E591-F84D-44E3-981A-AF97989940A1Q38205770-3807B9C3-D001-4ECC-B7F0-667AED29C595Q38236204-CD3A0C17-7651-4F8E-95FE-CB6B016E47B4Q39264494-97DD8BFB-B64E-471C-A8B6-120041124620Q42469426-D6AEE8B5-6E7B-4449-9B21-C41003BF46ECQ45875053-A74FB480-06CC-4F2F-A771-75BC9F3DA7B7Q50977853-81DADD1C-28DF-4EC8-9063-F9BB96B08ACA
P2860
In vivo expression of HGF/NK1 and GLP-1 From dsAAV vectors enhances pancreatic ß-cell proliferation and improves pathology in the db/db mouse model of diabetes.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
In vivo expression of HGF/NK1 ...... db/db mouse model of diabetes.
@ast
In vivo expression of HGF/NK1 ...... db/db mouse model of diabetes.
@en
In vivo expression of HGF/NK1 ...... db/db mouse model of diabetes.
@nl
type
label
In vivo expression of HGF/NK1 ...... db/db mouse model of diabetes.
@ast
In vivo expression of HGF/NK1 ...... db/db mouse model of diabetes.
@en
In vivo expression of HGF/NK1 ...... db/db mouse model of diabetes.
@nl
prefLabel
In vivo expression of HGF/NK1 ...... db/db mouse model of diabetes.
@ast
In vivo expression of HGF/NK1 ...... db/db mouse model of diabetes.
@en
In vivo expression of HGF/NK1 ...... db/db mouse model of diabetes.
@nl
P2093
P2860
P356
P1433
P1476
In vivo expression of HGF/NK1 ...... db/db mouse model of diabetes.
@en
P2093
Daniel F Gaddy
Michael J Riedel
Paul D Robbins
Sharmila Pejawar-Gaddy
P2860
P304
P356
10.2337/DB09-1886
P407
P577
2010-09-14T00:00:00Z